MONOAMINE METABOLITES IN CEREBROSPINAL FLUID IN RELATION TO DEPRESSIVE ILLNESS, SUICIDAL BEHAVIOUR AND PERSONALITY

[1]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[2]  Van Praag Hm.  Management of Depression With Serotonin Precursors , 1981 .

[3]  M. Åsberg,et al.  Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls , 1981, Psychiatry Research.

[4]  M. Åsberg,et al.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[5]  M. Åsberg,et al.  Cortisol in the CSF of depressed and suicidal patients. , 1980, Archives of general psychiatry.

[6]  G. Sedvall,et al.  Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity , 1980, British Journal of Psychiatry.

[7]  Bengt Winblad,et al.  SEASONAL AND CIRCADIAN MONOAMINE VARIATIONS IN HUMAN BRAINS EXAMINED POST MORTEM , 1980, Acta psychiatrica Scandinavica.

[8]  H. Praag,et al.  Central serotonin metabolism and frequency of depression , 1979, Psychiatry Research.

[9]  M. Åsberg,et al.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression , 1979, Clinical pharmacology and therapeutics.

[10]  D. Murphy,et al.  Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid , 1979, Journal of neurochemistry.

[11]  J. Korf,et al.  CORRELATIONS BETWEEN A FLUORIMETRIC and MASS FRAGMENTOGRAPHIC METHOD FOR THE DETERMINATION OF 3‐METHOXY‐4‐ HYDROXYPHENYLACETIC ACID and TWO MASS FRAGMENTOGRAPHIC METHODS FOR THE DETERMINATION OF 3‐METHOXY‐4‐ HYDROXYPHENYLETHYLENE GLYCOL IN CEREBROSPINAL FLUID , 1979, Journal of neurochemistry.

[12]  B. Johansson,et al.  A COMPARISON BETWEEN FLUOROMETRIC AND MASS FRAGMENTOGRAPHIC DETERMINATIONS OF HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN HUMAN CEREBROSPINAL FLUID , 1978, Journal of neurochemistry.

[13]  F. Goodwin,et al.  Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism. , 1978, Archives of general psychiatry.

[14]  D. Murphy,et al.  Suicide attempts, platelet monoamine oxidase and the average evoked response , 1977, Acta psychiatrica Scandinavica.

[15]  M. Åsberg,et al.  Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine , 1977, Clinical pharmacology and therapeutics.

[16]  D. Murphy,et al.  The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. , 1976, Science.

[17]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[18]  J. Maas.  Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.

[19]  E. Anggard,et al.  Concentration gradients of monoamine metabolites in human cerebrospinal fluid. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[20]  R. Ettlinger.  Evaluation of Suicide Prevention after Attempted Suicide , 1975, Acta psychiatrica Scandinavica. Supplementum.

[21]  M. Åsberg,et al.  Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression , 1974, European Journal of Clinical Pharmacology.

[22]  J. Korf,et al.  5-HYDROXYTRYPTOPHAN AS AN ANTIDEPRESSANT: THE PREDICTIVE VALUE OF THE PROBENECID TEST , 1974, The Journal of nervous and mental disease.

[23]  F. Goodwin,et al.  Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients. , 1974, Archives of general psychiatry.

[24]  J. Korf,et al.  Cerebral monoamines and depression. An investigation with the Probenecid technique. , 1973, Archives of general psychiatry.

[25]  M. Åsberg,et al.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline , 1973, Clinical pharmacology and therapeutics.

[26]  T. A. Kerr,et al.  Studies in the Classification of Affective Disorders , 1972, British Journal of Psychiatry.

[27]  T. A. Kerr,et al.  Studies in the Classification of Affective Disorders , 1972, British Journal of Psychiatry.

[28]  B. Johansson,et al.  Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. , 1971, Neuropharmacology.

[29]  F. Goodwin,et al.  Rapid elevation of biogenic amine metabolites in human CSF following probenecid. , 1970, Life sciences. Pt. 1: Physiology and pharmacology.

[30]  T. Chase,et al.  Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. , 1970, Neuropharmacology.

[31]  J. Korf,et al.  5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid , 1970, Nature.

[32]  W. Bunney,et al.  Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. , 1969, Archives of general psychiatry.

[33]  B. Roos,et al.  Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic Schizophrenics , 1969, British Journal of Psychiatry.

[34]  M. Bowers,et al.  Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to Age , 1968, Nature.

[35]  G. Sedvall,et al.  RELATIONSHIPS BETWEEN ABERRANT MONOAMINE METABOLITE CONCENTRATION IN CEREBROSPINAL FLUID AND FAMILY DISPOSITION FOR PSYCHIATRIC DISORDERS IN HEALTHY AND SCHIZOPHRENIC SUBJECTS , 1981 .

[36]  L. Oreland,et al.  Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behavior. , 1980, Progress in neuro-psychopharmacology.

[37]  M. Åsberg,et al.  Serotonin in Depressive Illness – Studies of CSF 5-HIAA , 1979 .

[38]  G. Sedvall,et al.  Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. , 1978, Communications in psychopharmacology.

[39]  D. Murphy,et al.  The brain serotonergic system in the affective disorders. , 1978, Progress in neuro-psychopharmacology.

[40]  H. Praag.  New Evidence of Serotonin-Deficient Depressions , 1977 .

[41]  F. Goodwin,et al.  Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. , 1973, The American journal of psychiatry.

[42]  F. Sjöqvist.  A pharmacokinetic approach to the treatment of depression. , 1971, International pharmacopsychiatry.